Febuxostat National Contract

Dept of Defense · United States government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$73.4M
Est. Value
April 07, 2027
Response Due
Active
Status

Opportunity Overview

Febuxostat National Contract is a request for proposal (rfp) for government procurement in United States, issued by Dept of Defense and tracked by GlobalGov. It falls under Pharmaceuticals. The estimated value is $73.4M. Responses are due by April 07, 2027. It was published on April 04, 2025. Classification: NAICS 325412, PSC 6505. Full solicitation details, all dates, and related live opportunities are below.

This is one of 124 active United States Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDept of Defense
CountryUnited States
CategoryPharmaceuticals
Estimated value$73.4M
NAICS325412
PSC6505
PublishedApril 04, 2025
Procurement stageRequest for Proposal (RFP)
Response dueApril 07, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

PPVG GEN V Award
National Retardant
PPVG GEN V AWARD SPE2DX25D8000
Ziprasidone Capsules
Hydrocodone Acetaminophen
Olanzapine SPE2D2-25-D-0011 Award
Olopatadine HCL 0.1% Ophthalmic Solution
Furosemide Tablets

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Pharmaceuticals intelligence report in your inbox

A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.